Amoxicillin Market Research Report 2024: Combination Therapies and Immunotherapy Trends Shaping Future Landscape - Global Long-term Forecast to 2028 and 2033
September 26, 2024 04:02 ET
|
Research and Markets
Dublin, Sept. 26, 2024 (GLOBE NEWSWIRE) -- The "Amoxicillin Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The amoxicillin market size has grown steadily in...
Developments in Nontuberculous Mycobacterial Infections Pipeline for 2024
September 25, 2024 04:07 ET
|
Research and Markets
Dublin, Sept. 25, 2024 (GLOBE NEWSWIRE) -- The "Nontuberculous Mycobacterial Infections - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering. Nontuberculous...
Tularemia Pipeline Landscape Report 2024: Current Treatment Paradigm and Future Prospects, Strategic Collaborations and Clinical Progress
September 24, 2024 10:13 ET
|
Research and Markets
Dublin, Sept. 24, 2024 (GLOBE NEWSWIRE) -- The "Tularemia - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering.The Tularemia pipeline landscape is witnessing a...
Antifungal Drugs Strategic Business Report 2024-2030: Trends in Prophylactic Use of Antifungal Drugs in High-Risk Populations Propel Market Growth - A US$22 Billion Market by 2030
September 17, 2024 07:51 ET
|
Research and Markets
Dublin, Sept. 17, 2024 (GLOBE NEWSWIRE) -- The "Antifungal Drugs - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Antifungal Drugs was...
Impetigo Drugs Global Strategic Business Report 2024 - Fusidane Drug Segment is Expected to Reach US$883.5 Million by 2030, with a CAGR of a 5.1%
September 02, 2024 05:59 ET
|
Research and Markets
Dublin, Sept. 02, 2024 (GLOBE NEWSWIRE) -- The "Impetigo Drugs - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Impetigo Drugs was...
H. (Helicobacter) Pylori Infection - 2024 Pipeline Insights Report Featuring Emerging Drugs Rifasutenizole (TNP-2198) by TenNor Therapeutics (Suzhou) Limited, and SVT1C4610 by Servatus Biopharmaceuticals
August 27, 2024 04:15 ET
|
Research and Markets
Dublin, Aug. 27, 2024 (GLOBE NEWSWIRE) -- The "Helicobacter Pylori Infection - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides...
Shingles Therapeutics Pipeline Market Insights Report 2024 Featuring Zhuhai Trinomab, Nobelpharma, Dynavax Technologies, Jiangsu Rec-Biotechnology, Moderna, Curevo, and Amytrx Therapeutics
August 20, 2024 11:07 ET
|
Research and Markets
Dublin, Aug. 20, 2024 (GLOBE NEWSWIRE) -- The "Shingles - Pipeline Insight, 2024" drug pipelines has been added to ResearchAndMarkets.com's offering.This "Shingles - Pipeline Insight, 2024" report...
Monkeypox Market Insight, Epidemiology and Market Forecast to 2034
August 19, 2024 04:19 ET
|
Research and Markets
Dublin, Aug. 19, 2024 (GLOBE NEWSWIRE) -- The "Monkeypox - Market Insight, Epidemiology and Market Forecast - 2034" report has been added to ResearchAndMarkets.com's offering.This report delivers...
Hepatitis B Virus Infection Pipeline Insight Report 2024: Therapeutic Assessment of 80+ Companies and 90+ Drugs
August 13, 2024 10:34 ET
|
Research and Markets
Dublin, Aug. 13, 2024 (GLOBE NEWSWIRE) -- The "Hepatitis B Virus Infection - Pipeline Insight, 2024" drug pipelines has been added to ResearchAndMarkets.com's offering.This "Hepatitis B Virus...
Tinea Pedis (Athlete`s Foot) Treatment Global Report 2024: Market to Grow by $300 Million by 2030 - Emergence of New Antifungal Agents Boosts Innovation
July 31, 2024 04:36 ET
|
Research and Markets
Dublin, July 31, 2024 (GLOBE NEWSWIRE) -- The "Tinea Pedis (Athlete`s Foot) Treatment - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global...